Break through the Noise
Media Intelligence and News Publishing Software for Innovators
Original News Stories pulled from Around Internet
Excessive Screen Time Linked to Increased Cardiometabolic Risks in Youth
A Danish study highlights the significant health risks associated with prolonged screen time among children and young adults, including higher chances …
August 6, 2025
Source
Allison Shawn's New Book Offers Hope and Guidance in Times of Stress
Allison Shawn's 'What On Earth Are We Doing?' provides a unique blend of memoir and self-help, offering practical steps for overcoming personal …
August 6, 2025
Source
ArcticCollagen Debuts on National Television, Redefining Collagen Supplementation
ArcticCollagen's national television debut highlights its innovative marine collagen supplement, offering a high-quality, convenient solution for …
August 6, 2025
Source
HeartBeam Inc. Secures Two New U.S. Patents for Innovative Cardiac Technology
HeartBeam Inc. enhances its cardiac diagnostics portfolio with two new U.S. patents for a portable 3D ECG device and a rhythm analysis algorithm, …
August 5, 2025
Source
Nutriband Inc. Announces 25% Preferred Stock Dividend Ahead of FDA Approval for AVERSA(TM) Fentanyl
Nutriband Inc. aligns shareholder rewards with regulatory milestones by announcing a 25% preferred stock dividend as it approaches FDA approval for …
August 5, 2025
Source
Aditxt Inc.'s Pending Acquisition Target CEO Honored for Women's Health Innovations
Saundra Pelletier, CEO of Evofem Biosciences, recognized with the Trailblazing Female Founders Award, highlighting the importance of advancements in …
August 5, 2025
Source
EnPlusOne Biosciences Innovates RNA Therapeutics with Enzymatic Synthesis Platform
EnPlusOne Biosciences introduces a groundbreaking enzymatic RNA synthesis platform, addressing scalability and purity challenges in RNA therapeutics …
August 5, 2025
Source
Quantum BioPharma Reports Positive Phase 1 Safety Results for Lucid-MS in Multiple Sclerosis Treatment
Quantum BioPharma Ltd. announces promising Phase 1 safety results for Lucid-MS, a novel neuroprotective compound aimed at treating multiple sclerosis …
August 5, 2025
Source
Epic Medical Research Joins hyperCORE International to Enhance Global Clinical Trials
Epic Medical Research's integration into hyperCORE International's network marks a significant advancement in clinical trial efficiency and scope …
August 5, 2025
Source
Soligenix Inc. Advances in Rare Disease Therapeutics with HyBryte(TM) Platform
Soligenix Inc. is making significant strides in rare disease therapeutics, particularly with its HyBryte(TM) platform for treating cutaneous T-cell …
August 5, 2025
Source
Clene Inc. to Showcase Innovative Neurodegenerative Disease Treatments at Canaccord Conference
Clene Inc. is set to present its pioneering therapy for neurodegenerative diseases at the Canaccord 45th Annual Growth Conference, highlighting a …
August 5, 2025
Source
Study Reveals Link Between Inflammation Markers and Depression Treatment Outcomes in Diabetics
Research highlights the impact of inflammation on depression treatment efficacy in diabetic patients, suggesting a need for personalized care …
August 5, 2025
Source
Innovative Breast Cancer Imaging Technology Addresses Global Demand
The article discusses the growing need for advanced breast cancer imaging technologies, highlighting Izotropic Corporation's IzoView Breast CT Imaging …
August 5, 2025
Source
Maryland Faces Multifaceted Challenges and Progresses in Renewable Energy
Maryland is navigating through juvenile justice reforms, transportation setbacks, and public health concerns while advancing in renewable energy and …
August 5, 2025
Source
Colorado Springs Man Overcomes Debilitating Back Injuries Through Innovative Treatment
Dustin Lewey's journey from severe back pain to recovery highlights the effectiveness of non-surgical, drug-free treatments at Thrive Health Systems.
August 5, 2025
Source
Beachway Therapy Center Highlights Importance of Support During National Recovery Month
Beachway Therapy Center emphasizes the significance of compassionate, evidence-based care and community support for individuals dealing with addiction …
August 4, 2025
Source
XOMA Royalty Corporation to Acquire LAVA Therapeutics N.V. in Strategic Move to Enhance Cancer Treatment Portfolio
XOMA Royalty Corporation's acquisition of LAVA Therapeutics N.V. for up to $1.24 per share plus a contingent value right aims to bolster its portfolio …
August 4, 2025
Source
Safe Pro Group's SpotlightAI to Enhance U.S. Army's Capabilities in 2026 Experiment
Safe Pro Group Inc.'s SpotlightAI platform will participate in the U.S. Army's Concept Focused Warfighting Experiment Maneuver in 2026, showcasing the …
August 4, 2025
Source
Advarra Appoints Brian Hart as New Chief Technology Officer to Drive Innovation in Clinical Research
Advarra strengthens its leadership with Brian Hart as CTO, aiming to enhance clinical research technology through his extensive healthcare tech …
August 4, 2025
Source
